ICER
1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Nov 11, 2025 by Dave Ricks · across every show →
Everything said about ICER, oldest first
Nov 11, 2025 positive
Ricks: ICER found tirzepatide and semaglutide cost-effective at current pricing
“They just analyzed our medicines, trisepatide and semaglutide, and they said, actually, they're both cost effective at current pricing. In fact, Zepbound or Trisepatide was, the threshold they have is to save a 100,000 dollars per person per year in downstream…”